Filing Details

Accession Number:
0001170362-12-000005
Form Type:
4
Zero Holdings:
No
Publication Time:
2012-07-03 20:51:38
Reporting Period:
2012-07-02
Filing Date:
2012-07-03
Accepted Time:
2012-07-03 19:51:38
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1080709 Arena Pharmaceuticals Inc ARNA Pharmaceutical Preparations (2834) 232908305
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1170362 W Steven Spector C/O Arena Pharmaceuticals, Inc.
6166 Nancy Ridge Drive
San Diego CA 92121
Evp, General Counsel & Sec No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2012-07-02 16,666 $6.00 76,254 No 4 M Direct
Common Stock Acquisiton 2012-07-02 22,699 $4.01 98,953 No 4 M Direct
Common Stock Acquisiton 2012-07-02 30,000 $3.25 128,953 No 4 M Direct
Common Stock Acquisiton 2012-07-02 45,000 $1.49 173,953 No 4 M Direct
Common Stock Disposition 2012-07-02 95,000 $9.96 78,953 No 4 S Direct
Common Stock Disposition 2012-07-02 39,365 $10.04 39,588 No 4 S Direct
Common Stock Acquisiton 2012-07-03 22,300 $4.01 61,888 No 4 M Direct
Common Stock Disposition 2012-07-03 22,300 $10.05 39,588 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 S Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Employee Stock Option (right to buy) Disposition 2012-07-02 16,666 $0.00 16,666 $6.00
Common Stock Employee Stock Option (right to buy) Disposition 2012-07-02 22,699 $0.00 22,699 $4.01
Common Stock Employee Stock Option (right to buy) Disposition 2012-07-02 30,000 $0.00 30,000 $3.25
Common Stock Employee Stock Option (right to buy) Disposition 2012-07-02 45,000 $0.00 45,000 $1.49
Common Stock Employee Stock Option (right to buy) Disposition 2012-07-03 22,300 $0.00 22,300 $4.01
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
33,334 2014-01-18 No 4 M Direct
37,301 2019-03-17 No 4 M Direct
70,000 2020-03-17 No 4 M Direct
255,000 2021-03-15 No 4 M Direct
15,001 2019-03-17 No 4 M Direct
Footnotes
  1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on April 11, 2012.
  2. The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $9.79 and $10.10 per share, inclusive. The reporting person undertakes to provide Arena Pharmaceuticals, Inc., any security holder of Arena Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 2 and 3 to this Form 4.
  3. The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $10.00 and $10.10 per share, inclusive.
  4. The options vested in four equal annual installments on January 18, 2005, 2006, 2007 and 2008, and were immediately exercisable.
  5. The options vest in four equal annual installments, and are exercisable once vested. The first, second and third installments became exercisable on March 17, 2010, 2011 and 2012, and the fourth installment vests on March 17, 2013.
  6. The options vest in four equal annual installments, and are exercisable once vested. The first and second installments became exercisable on March 17, 2011 and 2012, and the third and fourth installments vest on March 17, 2013 and 2014.
  7. The options vest in four equal annual installments, and are exercisable once vested. The first installment became exercisable on March 15, 2012, and the second, third and fourth installments vest on March 15, 2013, 2014 and 2015.